Back to 
BAMCO Inc.
BAMCO Inc.
ARWR
Showing 0 of 21 quarters
Position history for BAMCO Inc.'s holdings in Arrowhead Pharmaceuticals, Inc.
No. BAMCO exited its ARWR (Arrowhead Pharmaceuticals) position in Q4 2023. Its Q3 2023 13F listed 156,619 shares worth $4.2M. BAMCO already held ARWR in its Q4 2018 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.